Combined CSL and p53 downregulation promotes cancer-associated fibroblast activation.
Combined CSL and p53 downregulation promotes cancer-associated fibroblast activation.
复制标题
DOI:
10.1038/ncb3228
复制
发表时间:
2015-09
影响因子:
21.3
通讯作者:
Dotto GP
中科院分区:
文献类型:
--
作者:
Procopio MG;Laszlo C;Al Labban D;Kim DE;Bordignon P;Jo SH;Goruppi S;Menietti E;Ostano P;Ala U;Provero P;Hoetzenecker W;Neel V;Kilarski WW;Swartz MA;Brisken C;Lefort K;Dotto GP
Stromal fibroblast senescence has been linked to aging-associated cancer risk. However, density and proliferation of cancer-associated fibroblasts (CAF) are frequently increased. Loss or down-modulation of the Notch effector CSL/RBP-Jκ in dermal fibroblasts is sufficient for CAF activation and ensuing keratinocyte-derived tumors. We report that CSL silencing induces senescence of primary fibroblasts from dermis, oral mucosa, breast and lung. CSL functions in these cells as direct repressor of multiple senescence- and CAF-effector genes. It also physically interacts with p53, repressing its activity. CSL is down-modulated in stromal fibroblasts of premalignant skin actinic keratosis lesions and squamous cell carcinomas (SCC), while p53 expression and function is down-modulated only in the latter, with paracrine FGF signaling as likely culprit. Concomitant loss of CSL and p53 overcomes fibroblast senescence, enhances expression of CAF effectors and promotes stromal and cancer cell expansion. The findings support a CAF activation/stromal co-evolution model under convergent CSL/p53 control.